- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01227174
Safety and Efficacy of Propofol Only Sedation in Oral and Maxillofacial Surgery
Study Overview
Detailed Description
Removal of third molars is a common procedure performed in North America. Many surgeon choose to complete the procedure using procedural sedation. The most commonly used combination of medications to achieve procedural sedation consists of midazolam, fentanyl, and propofol. Propofol has been gaining increasing attention as a sedative agent due to its predictable pharmacokinetics and favorable amnestic properties. These properties make propofol an attractive sedative agent when compared to the benzodiazepines which are known to have a slower onset coupled with a much longer offset resulting in a prolonged sedative effect well beyond that required for completion of the procedure. Several studies have compared the use of propofol in combination with other sedatives with various control groups. These studies reliably confirm both the safety and efficacy of propofol. Some researches have speculated that the differences in nausea and vomiting reported by patients are secondary to the differences in dosage of fentanyl between groups. Others have concluded that fentanyl provides no advantage when using intermittent propofol in short duration procedures. Recent studies have found favourable results when using propofol only to achieve procedural sedation. On review of the Oral and Maxillofacial Surgery literature regarding this topic, a lack of internally and externally validated research was discovered. Oral and Maxillofacial surgical procedures are unique in duration of procedure and use of local anesthesia making it difficult to generalize data obtained from other specialties.
All eligible patients will be assigned to a single group. They will be asked to fill out a survey to determine their level of anxiety prior to the procedure. Participants will then proceed the same as non-study patients to see the nurse for a pre-operative assessment. After seeing the nurse, patients will see the surgeon for the procedure. Most of the data (blood pressure, heart rate, breathing rate etc.) is collected during the procedure. During procedural sedation monitoring is performed as usual but study patients will have capnometry added to the standard of care. Capnometry is a way of examining your breathing. It is the measurement of the carbon dioxide in the air that you breathe out through you nose. After the procedure is complete patients are transported to recovery where they must remain for a minimum of 30 minutes prior to discharge. The nurse in recovery will monitor you recovery continuously during your stay. The nurse will also apply a standard recovery score to your recovery every 5 minutes to track your progression. Once you are recovered from the procedural sedation you will be asked to complete a short questionnaire about your procedural sedation experience. After discharge patients will be contacted by phone 24 to 48 hours later to review a final questionnaire.
Study Type
Enrollment (Anticipated)
Phase
- Phase 4
Contacts and Locations
Study Contact
- Name: Ben Davis, DDS FRCD(C)
- Phone Number: 902 473 2070
- Email: bdavis@dal.ca
Study Contact Backup
- Name: James Brady, DDS BSc
- Phone Number: 902 473 7914
- Email: jrbrady@dal.ca
Study Locations
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada, B3H 2Y9
- Atlantic Centre for Oral and Maxillofacial Surgery 1278 Tower Rd.
-
Contact:
- Ben Davis, DDS FRCD(C)
- Phone Number: 902 473 2070
- Email: bdavis@dal.ca
-
Contact:
- James Brady
- Phone Number: 902 473 7914
- Email: jrbrady@dal.ca
-
Principal Investigator:
- Ben Davis, DDS FRCD(C)
-
Sub-Investigator:
- James Brady, DDS BSc
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- ASA Class I and II patients between the ages of 16 to 50 years scheduled to have their third molars extracted under intravenous sedation.
Exclusion Criteria:
- history of psychiatric illness, chronic use of central nervous system depressants or antidepressants, or alcohol abuse, had an active infection with systemic symptoms, were morbidly obese, were pregnant, or had a positive history of anesthetic-related complications.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Propofol sedation
Patients will be undergo procedural sedation using propofol.
|
Procedural sedation will be achieved using propofol
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pre-Sedation Behavioral Sate
Time Frame: Pre-operative assessment by RN the day of surgery just prior to entering the operating room.
|
Patient will complete Corah anxiety scale.
|
Pre-operative assessment by RN the day of surgery just prior to entering the operating room.
|
Efficacy of Sedation
Time Frame: Monitored using a post-operative questionnaire administered 30 minutes after arrival to the recovery room.
|
The patient does not have unpleasant recall of the procedure.
|
Monitored using a post-operative questionnaire administered 30 minutes after arrival to the recovery room.
|
Adverse outcome
Time Frame: Throughout the procedural sedation in a continuous fashion. The start time of the procedural sedation will be defined as the time of the first dose of propofol and the stop time will be the time that the patient is transferred to recovery.
|
Patient will be monitored for: apnea, aspiration, vomiting, cardiovascular events, excitatory movements, paradoxical response
|
Throughout the procedural sedation in a continuous fashion. The start time of the procedural sedation will be defined as the time of the first dose of propofol and the stop time will be the time that the patient is transferred to recovery.
|
Adverse outcomes
Time Frame: The patient will be monitored the recovery room in a continuous fashion for 30 minutes.
|
Unpleasant recovery reactions, permanent complications.
|
The patient will be monitored the recovery room in a continuous fashion for 30 minutes.
|
Patient Satisfaction
Time Frame: This will be measured 30 minutes after arrival to the recovery room and then once again via phone questionnaire between 24 to 48 hours after discharge.
|
A questionnaire will be given to the patient to complete just prior to discharge.
The patient will be contacted 24 to 48 hours after discharge to complete a second questionnaire.
|
This will be measured 30 minutes after arrival to the recovery room and then once again via phone questionnaire between 24 to 48 hours after discharge.
|
Level of sedation
Time Frame: This will be measured every 5 minutes throughout the duration of the procedural sedation.
|
The Ramsay sedation scale will be used to grade the depth of sedation during the procedure.
|
This will be measured every 5 minutes throughout the duration of the procedural sedation.
|
Surgeon satisfaction
Time Frame: Immediately after completing the surgical procedure.
|
The surgeon will complete a 5 point likert scale to determine their level of satisfaction.
|
Immediately after completing the surgical procedure.
|
Collaborators and Investigators
Investigators
- Principal Investigator: Ben Davis, DDS FRCD(C), Staff Surgeon at "Atlantic Centre for Oral and Maxillofacial Surgery"
Publications and helpful links
General Publications
- Zed PJ, Abu-Laban RB, Chan WW, Harrison DW. Efficacy, safety and patient satisfaction of propofol for procedural sedation and analgesia in the emergency department: a prospective study. CJEM. 2007 Nov;9(6):421-7. doi: 10.1017/s148180350001544x.
- Miner JR, Gray RO, Stephens D, Biros MH. Randomized clinical trial of propofol with and without alfentanil for deep procedural sedation in the emergency department. Acad Emerg Med. 2009 Sep;16(9):825-34. doi: 10.1111/j.1553-2712.2009.00487.x.
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CDHA-RS/2011-142
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Propofol
-
Postgraduate Institute of Medical Education and...Completed
-
University Hospital, Basel, SwitzerlandCompleted
-
Rutgers, The State University of New JerseyCompletedPropofol PollutionUnited States
-
University Hospital, LinkoepingCompleted
-
Qazvin University Of Medical SciencesCompletedPain Due to Propofol Injection | Hemodynamic Changes Due to Propofol InjectionIran, Islamic Republic of
-
University of Erlangen-Nürnberg Medical SchoolTerminated
-
University of PadovaRecruitingPropofol | Anesthesia Brain MonitoringItaly
-
Tao ZhangUnknownSevoflurane | Cesarean Section | PropofolChina
-
Ruhr University of BochumUnknownPropofol | Electroencephalography | Gender IdentityGermany
-
University of PadovaCompletedPropofol | Anesthesia Brain MonitoringItaly
Clinical Trials on Propofol
-
Hopital FochCompleted
-
Konkuk University Medical CenterCompletedCoronary Artery Disease | Valvular Heart DiseaseKorea, Republic of
-
University Medical Center GroningenCompletedAnesthesia | Hemodynamic Instability | Interaction | Disorder of Oxygen TransportNetherlands
-
Asan Medical CenterCompletedPopulation Pharmacokinetics/Pharmacodynamics (PK/PD) of Microemulsion Propofol in Healthy VolunteersHealthyKorea, Republic of
-
Tiva GroupMedtronic - MITGCompleted
-
Pontificia Universidad Catolica de ChileCompletedSurgery | Anesthesia | Depth of Anesthesia | NeonateChile
-
Mansoura UniversityCompleted
-
KVG Medical College and HospitalUnknown
-
Acibadem UniversityCompleted